In a special edition of What We’re Reading, the following is a compilation of reports, news stories and statements released in honor of World TB Day, March 24, 2011. Content includes a response from Secretary of State Hillary Clinton, a report from Médecins Sans Frontières highlighting the fight against drug resistant tuberculosis and the need for new drugs, and a call to make TB vaccine development a priority in the Decade of Vaccines.
Continuing our series in recognition of World TB Day, Science Speaks interviewed David Rochkind, a celebrated photographer whose work has appeared in numerous international publications such as The New York Times, The Guardian and Newsweek. After getting his undergraduate degree from the University of Michigan, he moved to Caracas, Venezuela where he worked for six years as a photographer for various U.S. and European news outlets. He has been in Mexico City for the past two years. David has done three photo exhibits on tuberculosis; the most recent of which will be on display today (Friday March 25) from 10 am to 4 pm, and Tuesday March 29 from 5:30 – 8:30 pm at Eastern Market in Washington, DC. His work will also be showing at Monmouth University in New Jersey for the month of April as part of their Global Understanding Conference.
In this interview, David talks about his most recent project covering multidrug-resistant TB in Eastern Europe.
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]